Foster Dykema Cabot & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $29M | Sell |
53,922
-115
| -0.2% | -$59.3K | 3.5% | 6 |
|
|
2023
Q2 | $25.3M | Sell |
54,037
-111
| -0.2% | -$46.5K | 2.98% | 6 |
|
|
2023
Q1 | $18.6M | Buy |
54,148
+1,238
| +2% | +$418K | 2.39% | 17 |
|
|
2022
Q4 | $19.4M | Buy |
52,910
+9,579
| +22% | +$3.4M | 2.71% | 11 |
|
|
2022
Q3 | $14M | Buy |
43,331
+40,278
| +1,319% | +$12.8M | 1.76% | 16 |
|
|
2022
Q2 | $990K | Hold |
3,053
| – | – | 0.12% | 40 |
|
|
2022
Q1 | $874K | Hold |
3,053
| – | – | 0.11% | 50 |
|
|
2021
Q4 | $843K | Hold |
3,053
| – | – | 0.1% | 52 |
|
|
2021
Q3 | $705K | Buy |
3,053
+1,269
| +71% | +$313K | 0.09% | 55 |
|
|
2021
Q2 | $409K | Hold |
1,784
| – | – | 0.05% | 68 |
|
|
2021
Q1 | $333K | Sell |
1,784
-60
| -3% | -$11.7K | 0.05% | 71 |
|
|
2020
Q4 | $311K | Buy |
1,844
+114
| +7% | +$17K | 0.04% | 78 |
|
|
2020
Q3 | $256K | Sell |
1,730
-21
| -1% | -$3.25K | 0.04% | 78 |
|
|
2020
Q2 | $287K | Buy |
1,751
+21
| +1% | +$3.22K | 0.05% | 77 |
|
|
2020
Q1 | $240K | Hold |
1,730
| – | – | 0.05% | 76 |
|
|
2019
Q4 | $227K | Buy |
+1,730
| New | +$201K | 0.03% | 90 |
|
|
2019
Q3 | – | Sell |
-4,150
| Closed | -$460K | – | 98 |
|
|
2019
Q2 | $460K | Sell |
4,150
-1,598
| -28% | -$188K | 0.07% | 76 |
|
|
2019
Q1 | $746K | Hold |
5,748
| – | – | 0.12% | 52 |
|
|
2018
Q4 | $665K | Sell |
5,748
-1,750
| -23% | -$195K | 0.12% | 54 |
|
|
2018
Q3 | $805K | Sell |
7,498
-1,750
| -19% | -$175K | 0.13% | 51 |
|
|
2018
Q2 | $906K | Hold |
9,248
| – | – | 0.15% | 44 |
|
|
2018
Q1 | $716K | Hold |
9,248
| – | – | 0.12% | 58 |
|
|
2017
Q4 | $781K | Sell |
9,248
-9,548
| -51% | -$812K | 0.13% | 56 |
|
|
2017
Q3 | $1.61M | Hold |
18,796
| – | – | 0.28% | 33 |
|
|
2017
Q2 | $1.55M | Hold |
18,796
| – | – | 0.28% | 35 |
|
|
2017
Q1 | $1.58M | Hold |
18,796
| – | – | 0.29% | 36 |
|
|
2016
Q4 | $1.38M | Sell |
18,796
-250
| -1% | -$18.6K | 0.26% | 42 |
|
|
2016
Q3 | $1.53M | Hold |
19,046
| – | – | 0.33% | 44 |
|
|
2016
Q2 | $1.5M | Hold |
19,046
| – | – | 0.35% | 38 |
|
|
2016
Q1 | $1.37M | Sell |
19,046
-300
| -2% | -$22.7K | 0.33% | 36 |
|
|
2015
Q4 | $1.63M | Sell |
19,346
-50
| -0.3% | -$4.15K | 0.41% | 33 |
|
|
2015
Q3 | $1.62M | Hold |
19,396
| – | – | 0.41% | 33 |
|
|
2015
Q2 | $1.62M | Hold |
19,396
| – | – | 0.42% | 33 |
|
|
2015
Q1 | $1.41M | Hold |
19,396
| – | – | 0.34% | 34 |
|
|
2014
Q4 | $1.34M | Hold |
19,396
| – | – | 0.32% | 36 |
|
|
2014
Q3 | $1.26M | Hold |
19,396
| – | – | 0.31% | 35 |
|
|
2014
Q2 | $1.21M | Hold |
19,396
| – | – | 0.29% | 38 |
|
|
2014
Q1 | $1.14M | Hold |
19,396
| – | – | 0.29% | 35 |
|
|
2013
Q4 | $989K | Sell |
19,396
-27
| -0.1% | -$1.35K | 0.26% | 39 |
|
|
2013
Q3 | $978K | Buy |
19,423
+27
| +0.1% | +$1.41K | 0.28% | 39 |
|
|
2013
Q2 | $953K | Buy |
+19,396
| New | +$1.06M | 0.28% | 40 |
|
Other funds holding LLY
Foster Dykema Cabot & Co's LLY Position: Q3 2023 in Review
Foster Dykema Cabot & Co reduced its Eli Lilly (LLY) stake by 0.21% in Q3 2023, selling an estimated $59.3K and leaving 53,922 shares worth $29M. The position accounts for 3.5% of the portfolio, ranked #6.
Foster Dykema Cabot & Co first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Foster Dykema Cabot & Co held 53,922 shares of Eli Lilly worth $29M as of Q3 2023.
- Foster Dykema Cabot & Co sold 115 Eli Lilly shares in Q3 2023, an estimated $59.3K.
- Eli Lilly made up 3.5% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #6 holding.
- Foster Dykema Cabot & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.